This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

Gillian Munson Biography and Net Worth

Director of Phreesia

Gillian is a partner at Union Square Ventures, a venture capital firm based in New York City, and has more than 25 years of corporate experience in the financial and technology industries. Prior to her current role, she spent seven years as Chief Financial Officer for XO Group, Inc., an online media and technology company, which she and her team sold in 2018. Previously, Gillian served as Managing Director at Allen & Company and Executive Director of Equity Research at Morgan Stanley. She also serves on the boards of Sweet Briar College and the St. Regis Foundation.

What is Gillian Munson's net worth?: The estimated net worth of Gillian Munson is at least $33,140.93 as of June 12th, 2023. Ms. Munson owns 1,619 shares of Phreesia stock worth more than $33,141 as of April 25th. This net worth approximation does not reflect any other assets that Ms. Munson may own. Learn More about Gillian Munson's net worth.
How do I contact Gillian Munson?: The corporate mailing address for Ms. Munson and other Phreesia executives is 432 Park Avenue South 12th Floor, New York NY, 10016. Phreesia can also be reached via phone at (888) 654-7473 and via email at [email protected]. Learn More on Gillian Munson's contact information.
Has Gillian Munson been buying or selling shares of Phreesia?: Gillian Munson has not been actively trading shares of Phreesia over the course of the past ninety days. Most recently, Gillian Munson sold 3,555 shares of the business's stock in a transaction on Wednesday, May 10th. The shares were sold at an average price of $30.06, for a transaction totalling $106,863.30. Following the completion of the sale, the director now directly owns 19,315 shares of the company's stock, valued at $580,608.90. Learn More on Gillian Munson's trading history.
Who are Phreesia's active insiders?: Phreesia's insider roster includes Edward Cahill (Director), Allison Hoffman (General Counsel), Chaim Indig (CEO), David Linetsky (SVP), Gillian Munson (Director), Randy Rasmussen (CFO), Evan Roberts (COO), Amy Vanduyn (SVP), and Michael Weintraub (Director). Learn More on Phreesia's active insiders.
Are insiders buying or selling shares of Phreesia?: In the last twelve months, insiders at the sold shares 44 times. They sold a total of 126,605 shares worth more than $2,850,272.12. The most recent insider tranaction occured on April, 18th when insider Janet Gunzburg sold 912 shares worth more than $20,839.20. Insiders at Phreesia own 5.8% of the company. Learn More about insider trades at Phreesia.
Information on this page was last updated on 4/18/2024.

Gillian Munson Insider Trading History at Phreesia

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/10/2023	Sell	3,555	$30.06	$106,863.30	19,315
7/11/2022	Sell	2,605	$25.59	$66,661.95	21,550
7/8/2021	Sell	3,055	$63.19	$193,045.45
6/12/2020	Sell	5,000	$28.32	$141,600.00

Gillian Munson Buying and Selling Activity at Phreesia

Phreesia Company Overview

Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.

Today's Range

Now: $20.47

$20.27

$21.67

50 Day Range

MA: $23.80

$20.47

$27.53

2 Week Range

Now: $20.47

$12.05

$34.98

Volume

599,305 shs

Average Volume

518,140 shs

Market Capitalization

$1.15 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.92

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad